Clinical Trial Update: Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury? [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating whether caffeine affects rosuvastatin’s protective effect against ischemia-reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Caffeine (caffeine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Ischemia Reperfusion Injury | Phase 4 | Status: COMPLETED